Literature DB >> 376175

Changes in diastolic time with various pharmacologic agents: implication for myocardial perfusion.

H Boudoulas, S E Rittgers, R P Lewis, C V Leier, A M Weissler.   

Abstract

Diastolic time (DT) is calculated as the cycle length (RR) minus electromechanical systole (QS2). The ratio of DT (RR-QS2) to RR interval times 100, or the percent diastole (%D), varies nonlinearly with heart rate (HR), increasing rapidly with decreasing HR. The effect of commonly used cardioactive agents on %D was studied in five groups of normal subjects. In group 1 (n = 12), propranolol (160 mg daily) increased %D from 55.9 +/- 1.7 to 64.7 +/- 1.3 (p less than 0.001) by slowing HR. In group 2 (n = 12), dobutamine (2.5 micrograms/kg/min) increased %D from 56.4 +/- 1.4 to 61.8 +/- 1.3 (p less than 0.005) by shortening the QS2. In group 3 (n = 10), Cedilanid-D (1.6 mg i.v.) increased %D from 55.5 +/- 1 to 63.2 +/- 0.7 (p less than 0.001), both by slowing the HR and shortening the QS2. In group 4 (n = 12), isoproterenol (2 micrograms/min) increased HR and shortened the QS2 significantly. The net result was a significant reduction of %D from 56.1 +/- 1.4 to 53.5 +/- 1.1, (p less than 0.05). In group 5 (n = 15), a 100-mg bolus of i.v. lidocaine did not have a significant effect on %D. This study indicates that cardiovascular drugs may have significant effects on the relative duration of diastole either by affecting HR or the duration of systole. This may have clinical implications for patients with coronary artery disease and patients with left ventricular hypertrophy, since in both cases coronary flow in mostly diastolic.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 376175     DOI: 10.1161/01.cir.60.1.164

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  26 in total

Review 1.  Potential interests of heart rate lowering drugs.

Authors:  T Laperche; D Logeart; A Cohen-Solal; R Gourgon
Journal:  Heart       Date:  1999-04       Impact factor: 5.994

Review 2.  Beta-blocker administration protocol for prospectively ECG-triggered coronary CT angiography.

Authors:  Akmal Sabarudin; Zhonghua Sun
Journal:  World J Cardiol       Date:  2013-12-26

Review 3.  According to MIAMI and ISIS-I trials, can a general recommendation be given for beta blockers in acute myocardial infarction?

Authors:  J K Kjekshus
Journal:  Cardiovasc Drugs Ther       Date:  1988-05       Impact factor: 3.727

4.  The comparative cardiovascular effects of digoxin and food alone and in combination in normal males.

Authors:  C D Burgess; J Crane
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

5.  Effects of the two enantiomers, S-16257-2 and S-16260-2, of a new bradycardic agent on guinea-pig isolated cardiac preparations.

Authors:  O Pérez; P Gay; L Franqueza; R Carrón; C Valenzuela; E Delpón; J Tamargo
Journal:  Br J Pharmacol       Date:  1995-07       Impact factor: 8.739

6.  Myocardial ischaemia. Dilemma between information available and information demand.

Authors:  M B Laver
Journal:  Br Heart J       Date:  1983-09

7.  Usefulness of the systolic time intervals in cardiovascular clinical cardiology.

Authors:  R P Lewis; H Boudoulas; C V Leier; D V Unverferth; A M Weissler
Journal:  Trans Am Clin Climatol Assoc       Date:  1982

8.  Cardiovascular effects of theophylline. Partial attenuation by beta-blockade.

Authors:  K A Conrad; E H Prosnitz
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

9.  Model prediction of subendocardial perfusion of the coronary circulation in the presence of an epicardial coronary artery stenosis.

Authors:  Jeroen P H M van den Wijngaard; Christina Kolyva; Maria Siebes; Jenny Dankelman; Martin J C van Gemert; Jan J Piek; Jos A E Spaan
Journal:  Med Biol Eng Comput       Date:  2008-05       Impact factor: 2.602

10.  Post-exercise contractility, diastolic function, and pressure: operator-independent sensor-based intelligent monitoring for heart failure telemedicine.

Authors:  Tonino Bombardini; Vincenzo Gemignani; Elisabetta Bianchini; Emilio Pasanisi; Lorenza Pratali; Mascia Pianelli; Francesco Faita; Massimo Giannoni; Giorgio Arpesella; Rosa Sicari; Eugenio Picano
Journal:  Cardiovasc Ultrasound       Date:  2009-05-14       Impact factor: 2.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.